By promoting the expression of Trx and phase II enzymes, SFN may be a useful preventative measure for retinal illnesses caused by photooxidative stress, which may worsen the severity and progression of AMD (Tanito et al., 2005). The gene discussed is SFN; the disease is age-related macular degeneration.